Godoy P, Hengstler JG, Ilkavets I, Meyer C, Bachmann A, Müller A, Tuschl
G, Mueller SO, Dooley S. Extracellular matrix modulates sensitivity of hepatocytes
to fibroblastoid dedifferentiation and transforming growth factor beta-induced
apoptosis. Hepatology. 2009 Jun;49(6):2031-43.
Brulport M, Schormann W, Bauer A, Hermes M, Elsner C, Hammersen FJ, Beerheide
W, Spitkovsky D, Härtig W, Nussler A, Horn LC, Edelmann J, Pelz-Ackermann
O, Petersen J, Kamprad M, von Mach M, Lupp A, Zulewski H, Hengstler JG: Fate
of extrahepatic human stem and precursor cells after transplantation into
mouse livers. Hepatology 2007;46:861-70.
Tanner B, Hasenclever D, Stern K, Schormann W, Bezler M, Hermes M, Brulport
M, Bauer A, Schiffer IB, Gebhard S, Schmidt M, Steiner E, Sehouli J, Edelmann
J, Lauter J, Lessig R, Krishnamurthi K, Ullrich A, Hengstler JG. ErbB-3 predicts
survival in ovarian cancer. J Clin Oncol. 2006 Sep 10;24(26):4317-23.
Schmidt M, Hengstler JG, von Törne C, Koelbl H, Gehrmann MC. Coordinates
in the universe of node-negative breast cancer revisited. Cancer Res.
2009 Apr 1;69(7):2695-8.
Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr
H-A, Hengstler JG, Kölbl H, Gehrmann M. The humoral immune system has
a key prognostic impact in node-negative breast cancer. Cancer Res
2008;68:5405-13.
Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA,
Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M, Sahin
U, Tureci O, Koelbl H, Hengstler JG, ERBB2-mediated transcriptional up-regulation
of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival
under adverse conditions. Cancer Res. 2006;66(7):3715-25.
Ruhnke M, Ungefroren H, Nussler A, Martin F, Brulport M, Schormann W, Hengstler
JG, Klapper W, Ulrichs K, Hutchinson JA, Soria B, Parwaresch RM, Heeckt P,
Kremer B, Fändrich F, Reprogramming of Human Peripheral Blood Monocytes
into Functional Hepatocyte and Pancreatic Islet-like Cells. Gastroenterology,
128:1774-86, 2005.
Trost TM, Lausch EU, Fees SA, Schmitt S, Enklaar T, Reutzel D, Brixel LR,
Schmidtke P, Maringer M, Schiffer IB, Heimerdinger CK, Hengstler JG, Fritz
G, Bockamp EO, Prawitt D, Zabel BU, Spangenberg C. Premature senescence is
a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma
cells. Cancer Res. 65:840-9, 2005.
Aurich H, Sgodda M, Kaltwaßer P, Vetter M, Weise A, Liehr T, Brulport
M, Hengstler JG, Dollinger MM, Fleig WE, Christ B. Hepatocyte differentiation
of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic
integration in vivo. GUT 2009;58:570-81.
Kiemeney, L.A. ..Golka K…, et al. Sequence variant on 8q24 confers
susceptibility to urinary bladder cancer. Nat. Genet. 40, 1307-1312
(2008).
Hewitt NJ, Lechon MJ, Houston JB, Hallifax D, Brown HS, Maurel P, Kenna
JG, Gustavsson L, Lohmann C, Skonberg C, Guillouzo A, Tuschl G, Li AP, LeCluyse
E, Groothuis GM, Hengstler JG. Primary hepatocytes: current understanding
of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical
practice for the use of hepatocytes in metabolism, enzyme induction, transporter,
clearance, and hepatotoxicity studies. Drug Metab Rev 2007;39:159-234.